+91-8668442535

Drug Eluting Stents Market By Product (Polymer Based Coating, Polymer Free Coating), By Application (Peripheral Artery Disease, Coronary Artery Disease) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

According to the World Health Organization's 2015 statistics, 82% of the 17 million premature deaths occurred in low and middle-income countries, with cardiovascular diseases accounting for 37% of these. The risk factors identified are associated with the worsening of the disease etiology related to cardiac complications ae, binge drinking, smoking, obesity, ty and type 2 diabetes is important to understand that blood vessel diseases have no symptoms; a heart attack or stroke are considered warning signs for the underlying diseases. Drug-eluting stents are important in cardiovascular complications because they are a minimally invasive surgical procedure that broadens constricted blood vessels and helps patients live longer lives.t.

Polymer-based coating and polymer-free coating have been included in the product segment. Polymer-based coatings are further sub-segmented as non-biodegradable and biodegradable polymer-based coatings. Polymer-free coatings comprise microporous surfaces, microstructured surfaces, slotted tubular surfaces, and nanoporous surfaces. The application segment comprises peripheral artery disease and coronary artery disease. With respect to the scope of the report, market estimation and forecasts for the period 2015–2025 are included in the document.

The scope of the report includes market sizing and data forecasts for the country's cross-sectional.

Porter's five forces model has been included in the scope of the report and gives a holistic view of the market dynamics prevalent in the drug-eluting stent market. The competitive landscape is a very useful study that gives insights regarding the competition faced by the major companies trying to gain a strong foothold in the drug-eluting stent market. The major players in the global drug-eluting stents market are Stentys, Abbott Laboratories, Inc., Biosensors International Group, Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology, Medtronics Plc, Terumo Medical Corporation, and Shandong JW Medical Systems.

Based on product, the global drug-eluting stents market is categorized into

  • Polymer-Based Coating
    • non-biodegradable polymer-based
    • Biodegradable polymer-based
  • Polymer-Free Coating
    • Microporous Surface
    • Microstructured Surface
    • Slotted Tubular Surface
    • Nanoporous Surface

Atherosclerotic plaques, which consist of cholesterol, fat, calcium, and other inflammatory substances present in the blood, usually build up in the arteries. It is of prime importance to understand the fatal outcomes of untreated atherosclerotic plaques, which may lead to stroke, heart attack, and death in severe cases. Polymer-free coated stents dominate the market due to their faster drug elution rate. Microporous surface stents are gaining tremendous demand due to their reduction of in-stent restenosis. Nanoporous surfaces have excellent features, such as higher drug loading capacity, which drives the market for polymer-free coating stents. Polymer-based coatings are gaining good momentum as they are useful in addressing the problems of local inflammation and neointimal hyperplasia by suppressing them and also providing sustained and controlled drug release for a longer period of time. The major players in the drug-eluting stents market are Abbott Laboratories, Inc., Biosensors International Group, Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology, Medtronics Plc, Terumo Medical Corporation, Shandong JW Medical Systems, Stentys.

Based on application, the global drug-eluting stents market is categorized into

  • Peripheral Artery Disease
  • Coronary Artery Disease

According to the World Health Organization, cardiovascular diseases are one of the prime causes of global deaths, accounting for 17.7 million deaths each year, which represents 31 percent of the deaths worldwide. Increased consumption of fast food, a profound smoking habit, obesity, and stress account for the morbidity due to stroke and heart attacks. It is noteworthy that 80% of all cardiovascular deaths are due to either strokes or heart attacks, which occur due to the narrowing of arteries due to atherosclerotic plaques causing hypertension and a reduced supply of oxygen. Coronary artery disease is the most prevalent condition in cardiovascular complications due to the increasing number of patients suffering from type-2 diabetes, excessive alcohol consumption, high levels of C-reactive proteins, and consumption of a poor diet deficient in vitamins E, D, and C. Peripheral artery disease is spreading at a faster pace as the blockage of arteries in the proximities causes claudication while walking and climbing erectile dysfunction in men, and sores and wounds of the feet that heal poorly.

For the purpose of this study, the global market for drug-eluting stents is categorized into the following regional and country-specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of the Middle East and Africa

North American dominance is related to the rising prevalence of the cardiovascular disease. The American Heart Association, in its 2017 Heart Disease and Strokes Statistics, has reported that cardiovascular disease is responsible for the deaths of around 800,000 U.S. citizens, which is equivalent to one in every three deaths. Sedentary lifestyles and rising consumption of saturated food products contribute to the growth of the North American drug-eluting stent market. The European market is driven by the rising prevalence of type 2 diabetes and obesity. The presence of pharmaceutical companies manufacturing drug-eluting stents represents Europe's market growth for drug-eluting stents. The presence of a large baby boomer population with cardiovascular complications, increasing public health awareness, and a supportive regulatory environment for drug-eluting stents drive the Asia Pacific market. Increased government spending on the establishment of developed healthcare centers, as well as foreign direct investment by healthcare medical device manufacturers, will drive the drug-eluting stent market in the Middle East, Africa, and Latin America to new heights. 

Frequently Asked Questions:

The market for Drug Eluting Stents is expected to reach US$ 8,377.9 Mn in 2025.

The Drug Eluting Stents market is expected to see significant CAGR growth over the coming years,at 5.67%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Abbott Laboratories Inc.,Biosensors International Group,Biotronik,Boston Scientific Corporation,Cook Medical are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Dec 2017
Category:  Medical Devices
Report ID:   58866
Report Format:   PDF
Pages:   120
Rating:    4.8 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support